bioAffinity Technologies, Inc. (BIAFW) Operating income 2021–2025
bioAffinity Technologies, Inc. (BIAFW) annual operating income history from SEC filings — each fiscal year as reported.
-$10.6MFY2025 · since FY2021: -$2.2M → -$10.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.6M | -18.1% |
| FY2024 | -$9.0M | -12.3% |
| FY2023 | -$8.0M | -98.8% |
| FY2022 | -$4.0M | -81.8% |
| FY2021 | -$2.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BIAFW financial trends
BIAFW RevenueBIAFW Net incomeBIAFW Net marginBIAFW Gross profitBIAFW Gross marginBIAFW Operating marginBIAFW Operating cash flowBIAFW Free cash flowBIAFW Capital expendituresBIAFW Return on equityBIAFW Stock buybacksBIAFW Dividends paidBIAFW Total assetsBIAFW Total liabilitiesBIAFW Shareholders’ equityBIAFW overview →